Kotak Institutional Equities has refreshed its model portfolios, adding TCS, SBI Life Insurance, CRISIL, and DCB Bank. The brokerage adjusted these holdings following recent market gains that reduced the upside potential for several previously held stocks. This move reflects a shift in strategy as analysts look for better value in a recovering market.
Kotak Institutional Equities has updated its model portfolios for Indian investors, bringing in new names while trimming stakes in stocks that have already seen significant price appreciation. The brokerage firm explained that a strong market recovery in recent months has made it necessary to adjust holdings, as the potential for further near-term gains in some top performers has started to narrow.
In the large-cap portfolio, Kotak has added SBI Life Insurance and Tata Consultancy Services (TCS), each with a 1.5% allocation. The firm also increased its stake in Larsen & Toubro by 1 percentage point, bringing it to 4%. These additions come at a time when analysts are re-evaluating risk-reward ratios after a sustained period of market growth. Regarding SBI Life, the brokerage pointed toward its valuation relative to its embedded value, which is a common metric used to assess the health of insurance companies. For TCS, the adjustment reflects the firm's outlook on its earnings potential relative to its current market price.
To balance these additions, the firm removed Mankind Pharma from its large-cap list and reduced its exposure to DLF and GMR Airports. These decisions were driven by the fact that these stocks had already experienced significant price gains recently, which the brokerage believes limits their potential for further growth toward the firm's price targets.
Mid-Cap Portfolio Changes
The mid-cap strategy also underwent a major shake-up with the inclusion of CRISIL and DCB Bank. Additionally, ICICI Prudential Life was moved into the mid-cap portfolio from the large-cap segment. To accommodate these new positions, Kotak removed Dixon Technologies, Delhivery, and Info Edge. The firm noted that the stocks removed from the mid-cap list had delivered strong returns in the past one to three months, making their risk-reward profile less attractive compared to the newly added companies.
For investors, these portfolio changes highlight how institutional analysts respond when stock prices climb quickly. When a stock hits or nears a brokerage's fair value target due to a rapid rally, firms often rotate capital into companies they believe still offer better value or have more room for earnings growth.
Investors tracking these changes should focus on the underlying reasons for the churn, such as valuation concerns versus long-term business fundamentals. The next important step for investors is to observe whether these new additions meet their own investment goals and how the companies perform in upcoming quarterly results, which will provide more data on whether the earnings growth matches the expectations set by brokerage analysts.